Dyslipidaemia Clinical Trial
Official title:
Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia
The purpose of the study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the All-Russian Scientific Cardiology Society guidelines/ the 4th Joint European Task Force guidelines.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02230241 -
CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)
|
N/A | |
Completed |
NCT04641299 -
A Study of AZD8233 in Participants With Dyslipidemia
|
Phase 2 | |
Completed |
NCT01451918 -
Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol
|
Phase 2 | |
Recruiting |
NCT01212328 -
A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia
|
N/A | |
Completed |
NCT00654225 -
Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)
|
Phase 3 | |
Withdrawn |
NCT02557412 -
Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea
|
N/A | |
Completed |
NCT00653965 -
Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)
|
Phase 3 | |
Recruiting |
NCT04442334 -
The European NAFLD Registry
|
||
Completed |
NCT00653744 -
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
|
Phase 3 | |
Completed |
NCT01632358 -
Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients
|
Phase 1 | |
Completed |
NCT02523391 -
Bioequivalence Study of Capsule and Tablet Formulations of TA-8995
|
Phase 1 | |
Completed |
NCT00474864 -
Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.
|
Phase 2 | |
Completed |
NCT00659321 -
Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
|
Phase 3 | |
Completed |
NCT01055977 -
Statin Therapy Results in the Real World Practice in the Czech Republic
|
N/A | |
Completed |
NCT00654602 -
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
|
Phase 3 | |
Recruiting |
NCT05979428 -
A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood
|
Phase 1 | |
Completed |
NCT02241759 -
Study of the Electrocardiographic Effects of TA-8995
|
Phase 1 | |
Completed |
NCT00158899 -
GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
|
Phase 2 |